Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives
- PMID: 2298967
- DOI: 10.1016/0190-9622(90)70010-f
Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives
Abstract
Dysplastic melanocytic nevi are potential precursors of cutaneous melanoma and markers of increased risk. This article presents representative case histories that illustrate the usefulness of careful follow-up of persons who have dysplastic melanocytic nevi or cutaneous melanoma, as well as examination of their blood relatives for the same lesions. Identification and periodic examination of such high-risk persons may result in the detection of melanoma in a curable phase. Our observations suggest that (1) dysplastic melanocytic nevi may aggregate in families of persons who have dysplastic melanocytic nevi or melanoma, even in the absence of a family history of dysplastic melanocytic nevi or melanoma and (2) formal genetic and natural history studies of persons who have dysplastic melanocytic nevi outside the familial melanoma setting are warranted.
Similar articles
-
Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families.J Am Acad Dermatol. 1995 Oct;33(4):631-6. doi: 10.1016/0190-9622(95)91284-3. J Am Acad Dermatol. 1995. PMID: 7673498
-
Familial and cutaneous features of dysplastic nevi: a case-control study.J Am Acad Dermatol. 1993 Apr;28(4):558-64. doi: 10.1016/0190-9622(93)70074-4. J Am Acad Dermatol. 1993. PMID: 8463456
-
Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.Hum Pathol. 1998 Jan;29(1 Suppl 1):S1-24. doi: 10.1016/s0046-8177(98)80028-2. Hum Pathol. 1998. PMID: 9445124
-
Dysplastic nevi.Dermatol Clin. 2012 Jul;30(3):389-404. doi: 10.1016/j.det.2012.04.004. Epub 2012 Jun 8. Dermatol Clin. 2012. PMID: 22800547 Review.
-
Dysplastic melanocytic nevus: Are molecular findings the key to the diagnosis?Ann Diagn Pathol. 2022 Oct;60:152006. doi: 10.1016/j.anndiagpath.2022.152006. Epub 2022 Jul 8. Ann Diagn Pathol. 2022. PMID: 35839551 Review.
Cited by
-
Survival is not the only valuable end point in melanoma screening.J Invest Dermatol. 2012 May;132(5):1332-7. doi: 10.1038/jid.2012.3. Epub 2012 Feb 16. J Invest Dermatol. 2012. PMID: 22336950 Free PMC article. Review. No abstract available.
-
Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.Br J Cancer. 1996 Jun;73(12):1605-11. doi: 10.1038/bjc.1996.302. Br J Cancer. 1996. PMID: 8664138 Free PMC article.
-
Melanoma risk factors and atypical moles.West J Med. 1994 Apr;160(4):343-50. West J Med. 1994. PMID: 8023484 Free PMC article. Review.
-
Pigmentary Markers in Danes--Associations with Quantitative Skin Colour, Nevi Count, Familial Atypical Multiple-Mole, and Melanoma Syndrome.PLoS One. 2016 Mar 3;11(3):e0150381. doi: 10.1371/journal.pone.0150381. eCollection 2016. PLoS One. 2016. PMID: 26938746 Free PMC article.
-
Differences and Similarities in Epidemiology and Risk Factors for Cutaneous and Uveal Melanoma.Medicina (Kaunas). 2023 May 14;59(5):943. doi: 10.3390/medicina59050943. Medicina (Kaunas). 2023. PMID: 37241175 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical